Cahill Thomas has filed 7 insider transactions across 1 company since June 2023.
Most recent transaction: a disposition of 39062 shares of Prime Medicine, Inc. ($PRME) on August 01, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 1, 2025 | Prime Medicine, Inc. | $PRME | Cahill Thomas | Director | D | Stock Option (right to buy) | 39062 | $0.00 | 0.0000 | 131,160,842 | 100.00% | 0.03% |
| Aug. 1, 2025 | Prime Medicine, Inc. | $PRME | Cahill Thomas | Director | A | Stock Option (right to buy) | 39062 | $0.00 | 39,062.0000 | 131,160,842 | 9999.99% | 0.03% |
| Aug. 1, 2025 | Prime Medicine, Inc. | $PRME | Cahill Thomas | Director | D | Stock Option (right to buy) | 45000 | $0.00 | 0.0000 | 131,160,842 | 100.00% | 0.03% |
| Aug. 1, 2025 | Prime Medicine, Inc. | $PRME | Cahill Thomas | Director | A | Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 131,160,842 | 9999.99% | 0.03% |
| June 4, 2025 | Prime Medicine, Inc. | $PRME | Cahill Thomas | Director | A | Stock Option (right to buy) | 55000 | $0.00 | 55,000.0000 | 131,160,842 | 9999.99% | 0.04% |
| June 12, 2024 | Prime Medicine, Inc. | $PRME | Cahill Thomas | Director | A | Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Prime Medicine, Inc. | $PRME | Cahill Thomas | Director | A | Stock Option (right to buy) | 39062 | $0.00 | 39,062.0000 | 0 | 9999.99% | 0.00% |